ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Right-Sided Extravalvular Damage: An Overlooked Driver of Risk Model Failure in Low-Flow, Low-Gradient Aortic Stenosis.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score is guideline-endorsed for estimating procedural risk in aortic stenosis (AS) but tends to overestimate long-term mortality after transcatheter aortic valve replacement (TAVR). This study aimed to evaluate whether markers of right-sided extravalvular damage improve STS-PROM's performance in predicting 1-year mortality post-TAVR for patients with low-flow, low-gradient AS. Methods: Four hundred ten patients with valve area ≤1.0 cm Results: Right-sided extravalvular damage was independently associated with increased 1-year mortality (OR, 2.45; 95% CI, 1.34-4.46; Conclusions: Markers of right-sided extravalvular damage conferred meaningful prognostic value in low-flow, low-gradient AS by correcting the STS-PROM score's tendency to overestimate post-TAVR mortality. The added value of these markers was most pronounced in moderate-risk patients, for whom existing tools appear least reliable. These markers may improve patient selection for TAVR and merit evaluation in other severe AS phenotypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.